A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma

Cancer Letters

Volumn 275, Issue 1, 2009, Pages 72-76

  Zhou, Bin ^a   Rao, Li ^b   Li, Yi ^c   Gao, Linbo ^c   Wang, Yanyun ^c   Chen, Yu ^b   Xue, Hui ^b   Song, Yaping ^a   Peng, Ying ^b   Liao, Miao ^c   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Genetic association; Nasopharyngeal carcinoma; NF B; NFKB1; Polymorphism

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; ALLELES; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 58549113421     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.002     Document Type: Article

References (37)

1. Wei W.I., and Sham J.S. Nasopharyngeal carcinoma. Lancet 365 9476 (2005) 2041-2054
2. D.M. Parkin, S.L. Whelan, J. Ferlay, L. Teppo, D.B. Thomas, Cancer Incidence in Five Continents, vol. VIII, IARC scientific publications No. 155, 2002, pp. 1-781.
3. Chang E.T., and Adami H.O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 15 10 (2006) 1765-1777
4. Suarez C., Rodrigo J.P., Ferlito A., Cabanillas R., Shaha A.R., and Rinaldo A. Tumours of familial origin in the head and neck. Oral Oncol. 42 10 (2006) 965-978
5. Friborg J., Wohlfahrt J., Koch A., Storm H., Olsen O.R., and Melbye M. Cancer susceptibility in nasopharyngeal carcinoma families - a population-based cohort study. Cancer Res. 65 18 (2005) 8567-8572
6. Friborg J., Wohlfahrt J., and Melbye M. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer 103 1 (2005) 211-212
7. Lu S.J., Day N.E., Degos L., Lepage V., Wang P.C., Chan S.H., Simons M., McKnight B., Easton D., Zeng Y., et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 346 6283 (1990) 470-471
8. Hildesheim A., Apple R.J., Chen C.J., Wang S.S., Cheng Y.J., Klitz W., Mack S.J., Chen I.H., Hsu M.M., Yang C.S., Brinton L.A., Levine P.H., and Erlich H.A. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J. Natl. Cancer Inst. 94 23 (2002) 1780-1789
9. Zhou X., Cui J., Macias V., Kajdacsy-Balla A.A., Ye H., Wang J., and Rao P.N. The progress on genetic analysis of nasopharyngeal carcinoma. Comp. Funct. Genomics (2007) 57513
10. Lo K.W., To K.F., and Huang D.P. Focus on nasopharyngeal carcinoma. Cancer Cell 5 5 (2004) 423-428
11. Jeyakumar A., Brickman T.M., Jeyakumar A., and Doerr T. Review of nasopharyngeal carcinoma. Ear Nose Throat J 85 3 (2006) 168-170 172-163, 184
12. Kaye K.M., Izumi K.M., and Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90 19 (1993) 9150-9154
13. Izumi K.M. Identification of EBV transforming genes by recombinant EBV technology. Semin. Cancer Biol. 11 6 (2001) 407-414
14. Yoshizaki T., Sato H., Furukawa M., and Pagano J.S. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl. Acad. Sci. USA 95 7 (1998) 3621-3626
15. Kim K.R., Yoshizaki T., Miyamori H., Hasegawa K., Horikawa T., Furukawa M., Harada S., Seiki M., and Sato H. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19 14 (2000) 1764-1771
16. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., and Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80 3 (1995) 389-399
17. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16 20 (1997) 6131-6140
18. Zheng H., Li L.L., Hu D.S., Deng X.Y., and Cao Y. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell. Mol. Immunol. 4 3 (2007) 185-196
19. Yin L., Liao W., Deng X., Tang M., Gu H., Li X., Yi W., and Cao Y. LMP1 activates NF-kappa B via degradation of I kappa B alpha in nasopharyngeal carcinoma cells. Chin. Med. J. 114 7 (2001) 718-722
20. Chen F., Castranova V., Shi X., and Demers L.M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 45 1 (1999) 7-17
21. Karban A.S., Okazaki T., Panhuysen C.I., Gallegos T., Potter J.J., Bailey-Wilson J.E., Silverberg M.S., Duerr R.H., Cho J.H., Gregersen P.K., Wu Y., Achkar J.P., Dassopoulos T., Mezey E., Bayless T.M., Nouvet F.J., and Brant S.R. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum. Mol. Genet. 13 1 (2004) 35-45
22. Rueda B., Nunez C., Lopez-Nevot M.A., Paz Ruiz M., Urcelay E., De la Concha E.G., and Martin J. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease. Scand. J. Gastroenterol. 41 4 (2006) 420-423
23. Oliver J., Gomez-Garcia M., Paco L., Lopez-Nevot M.A., Pinero A., Correro F., Martin L., Brieva J.A., Nieto A., and Martin J. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Inflamm. Bowel Dis. 11 6 (2005) 576-579
24. Li H., Gao L., Shen Z., Li C.Y., Li K., Li M., Lv Y.J., Li C.X., Gao T.W., and Liu Y.F. Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris. Arch. Dermatol. Res. (2008)
25. Lin S.C., Liu C.J., Yeh W.I., Lui M.T., Chang K.W., and Chang C.S. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett. 243 1 (2006) 47-54
26. Chien Y.C., Chen J.Y., Liu M.Y., Yang H.I., Hsu M.M., Chen C.J., and Yang C.S. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N. Engl. J. Med. 345 26 (2001) 1877-1882
27. Ho J.H. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 4 3-4 (1978) 182-198
28. Hiyama T., Yoshihara M., Tanaka S., and Chayama K. Genetic polymorphisms and head and neck cancer risk (review). Int. J. Oncol. 32 5 (2008) 945-973
29. Eliopoulos A.G., and Young L.S. LMP1 structure and signal transduction. Semin. Cancer Biol. 11 6 (2001) 435-444
30. Li H.P., and Chang Y.S. Epstein-Barr virus latent membrane protein 1: structure and functions. J. Biomed. Sci. 10 5 (2003) 490-504
31. Yang J., Pan W.H., Clawson G.A., and Richmond A. Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth. Cancer Res. 67 7 (2007) 3127-3134
32. Criswell T.L., and Arteaga C.L. Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motility. J. Biol. Chem. 282 44 (2007) 32491-32500
33. Loercher A., Lee T.L., Ricker J.L., Howard A., Geoghegen J., Chen Z., Sunwoo J.B., Sitcheran R., Chuang E.Y., Mitchell J.B., Baldwin Jr. A.S., and Van Waes C. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res. 64 18 (2004) 6511-6523
34. Sunwoo J.B., Chen Z., Dong G., Yeh N., Crowl Bancroft C., Sausville E., Adams J., Elliott P., and Van Waes C. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin. Cancer Res. 7 5 (2001) 1419-1428
35. Lo A.K., Lo K.W., Tsao S.W., Wong H.L., Hui J.W., To K.F., Hayward D.S., Chui Y.L., Lau Y.L., Takada K., and Huang D.P. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia (New York, NY) 8 3 (2006) 173-180
36. Borm M.E., van Bodegraven A.A., Mulder C.J., Kraal G., and Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int. J. Immunogenet. 32 6 (2005) 401-405
37. Bu H., Rosdahl I., Sun X.F., and Zhang H. Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J. Cancer Res. Clin. Oncol. 133 11 (2007) 859-866